Lecture 11b Clinical uses of adrenergic agonists.

Slides:



Advertisements
Similar presentations
IM Epinephrine Administration by the EMT
Advertisements

Sympathetic Drugs. Stress and The Adrenal Glands.
PHARMACOLOGY OF SNS.
Antiarrhythmic Agents: Cardiac Stimulants and Depressants
CNS STIMULANTS SAMUEL AGUAZIM. What is the definition of a CNS stimulant? A CNS stimulant is a drug that increases motor activity, causes excitement and.
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Adrenoceptor Blockers Adrenolytics Adrenergic Neuron Blockers Sympatholytics According to spectrum of action According to chemistry According to mode.
Chapter 5 Autonomic Drugs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
ADRENERGIC ANTAGONITS
PHARMAKOLOGY VASOPRESSOR DRUGS DJUDJUK RAHMAD BASUKI Lab.Anestesi dan Terapi Intensive RSSA Malang.
1.  It is the major constituent of the adrenal medulla secretion (80%).  Hydrochloride aqueous solutions are hydrolyzed rapidly in alkaline or neutral.
Autonomic Nervous System
ADRENERGIC RECEPTORS AND DRUGS
Adrenergic Agonists (Sympathomimetics)
OBJECTIVES At the end of lectures the students should Describe the different classes of drugs used for treatment of acute & chronic heart failure.
Adrenergic & Antiadrenergic Drugs By Dr. F. Tavakoli.
Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors  Alpha-(α-) adrenergic receptors,
Sympathomimetics (continue)
SYMPATHOMIMETIC DRUGS
SYMPATHOMIMETICS Classification: A- According to the source:
Vasopressors.
Adrenergic agonists Samuel Aguazim (MD).
Adrenergic preparations
Chapter 33 Agents Affecting the Autonomic Nervous System.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Synthesis & Release of Neurotransmitters
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Adrenergic Agonists Prof. A. Alhaider. Tyrosine Dopa DA NE Na COMT NET Ca Norepinephrine (NE) SYNTHESIS STORAGE RELEASE ACTION REUPTAKE DEGRADE POSTGANGLIONIC.
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
AUTONOMIC NERVOUS SYSTEM LECTURE 6 PHARMACOLOGY. Autonomic Pharmacology Autonomic Nervous System – This system is divided into two separate systems. –
Actions of epinephrine:
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
Adrenergic Antagonists
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
SYMPATHOMIMETIC AGENTS
Adrenergic Agonists.
Adrenergic Antagonists
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Antimuscarinic Agents
Adrenergic agonist: PHARMACOLOGY OF SNS.
Adrenergic drugs.
Pharmacological actions of cathecholamines
School of Pharmacy, University of Nizwa
Chapter 5 Autonomic Drugs.
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Beta-adrenergic blocking agents
Drugs Acting on the Heart
Adrenergic [ædrə‘nədʒik] agonists
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic Agonists.
Adrenergic agonists and antagonists
Adrenergic agonists ILOS
Vasoconstrictors Originally added to reduce systemic uptake in an attempt to limit toxicity. Prolong the duration Produces profound anaesthesia. Reduce.
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

Lecture 11b Clinical uses of adrenergic agonists

Clinical Uses of Adrenergic Agonists Cardiovascular:  Cardiogenic Shock, Cardiac arrest: β agonist: Adrenaline, dobutamine or dopamine Dopamine is clinically more useful in the treatment of shock, in which significant increase in sympathetic activity might compromise renal function and worsens the peripheral circulation  Malignant hypertension: α2 agonist: Clonidine  HYPOTENSION: α1 agonist phenylephrine  Heart block : β agonist: isoprenaline  It’s only used now to reverse the block which is produced by overdoses of β – blockers

N.B. cardiac arrest means : complete cessation of heart’s activity. While heart block means : partial or complete inhibition of the spread of conduction of the electrical impulse from the atria to the ventricles Anaphylactic reactions: Ad is the first line of treatment for bronchoconstriction & CV collapse Both β and α agonist required. We use EP with steroid and antihistamine to cause Bronchodilation, Increase BP

Clinical Uses of Adrenergic Agonists (cont.) Respiratory:  Asthma and premature labor contractions: For treatment » Isoprenaline (β agonist), Salbutamol, Terbutalin & Salmeterol (selective β2 is preferred) For prophylaxis » Salmeterol & Formoterol Norepinephrine is NOT used in treatment of asthma  Nasal Decongestion: Ephedrine  Haemostatic in epistaxis: Adrenaline & Ephedrine Miscellaneous:  Mydriatic: Ephedrine  Glaucoma: Adrenaline decrease IOP in open angel glaucoma, decrease aqueous humor production by VC of ciliary body BV.  Depression: Amphetamine ritordine

With local anesthetics: Adrenaline & NA These drugs are used in dentistry because of their vasoconstrictive actions on blood vessels. They are added to local anesthetics because they prolong the action of the local anesthetic, reduce the risk for systemic toxicity, and help to create a dry field.

Central Nervous System Stimulation These medications are used for the treatment of attention deficit hyperactivity disorder, narcolepsy, and as diet aids.

Adverse Effects –CNS disturbance: anxiety, fear, tension, headache & tremors –Cerebral hemorrhage –Tachycardia & Cardiac arrhythmias –Tachyphylaxis occurs with indirectly acting drugs

Contraindications to use of adrenergics Cardiac dysrhythmias, angina pectoris Hypertension Hyperthyroidism Cerebrovascular disease Distal areas with a single blood supply such as fingers, toes, nose and ears Renal impairment use caution

Toxicity of adrenergics in critically ill patients Affects renal perfusion Can induce cardiac dysrhythmias Increases myocardial oxygen consumption May decrease perfusion of liver Tissue necrosis with extravasation

Epinephrine Actions: 1- Cardiovascular: strengthens the contractility of the myocardium (positive inotropic) and increases its rate of contraction (positive chronotropic). Cardiac output therefore increases. With these effects comes increased oxygen demands on the myocardium. Epinephrine constricts arterioles in the skin, mucous membranes, and viscera (α effects), and it dilates vessels going to the liver and skeletal muscle.

Therefore, the cumulative effect is an increase in systolic blood pressure, coupled with a slight decrease in diastolic pressure. 2- Respiratory: Epinephrine causes powerful bronchodilation by acting directly on bronchial smooth muscle. This action relieves all known allergic- or histamine-induced bronchoconstriction. In the case of anaphylactic shock, this can be lifesaving. 3- hyperglycemia 4- lipolysis

Pharmacokinetics: Epinephrine has a rapid onset but a brief duration of action (due to rapid degradation). In emergency situations, epinephrine is given intravenously for the most rapid onset of action. It may also be given subcutaneously, by endotracheal tube, by inhalation, or topically to the eye. Oral administration is ineffective, because epinephrine and the other catecholamines are inactivated by intestinal enzymes. Only metabolites are excreted in the urine.

Biotransformation: Epinephrine, like the other catecholamines, is metabolized by two enzymatic pathways: MAO, and COMT. Therapeutic uses: 1.bronchospasm 2.Glaucoma 3.Anaphylactic shock 4.Cardiac arrest 5.With anasethtics

Adverse effects: 1.CNS disturbances: 2.Hemorrhage: The drug may induce cerebral hemorrhage as a result of a marked elevation of blood pressure. 3.Cardiac arrhythmias: Epinephrine can trigger cardiac arrhythmias, particularly if the patient is receiving. 4.Pulmonary edema: Epinephrine can induce pulmonary edema

Interactions: 1.Hyperthyroidism: Epinephrine may have enhanced cardio-vascular actions in patients with hyperthyroidism. involve increased production of adrenergic receptors on the vasculature of the hyperthyroid individual, leading to a hypersensitive response. 2. Cocaine: In the presence of cocaine, epinephrine produces exaggerated cardiovascular actions. This is due to the ability of cocaine to prevent reuptake of catecholamines into the adrenergic neuron; thus, like norepinephrine, epinephrine remains at the receptor site for longer periods of time. 3. Inhalation anesthetics: Inhalational anesthetics sensitizethe heart to the effects of epinephrine, which may lead to tachycardia.

4. Diabetes: Epinephrine increases the release of endogenous stores of glucose. In the diabetic, dosages of insulin may have to be increased. 5. β-Blockers: These agents prevent epinephrine's effects on β receptors, leaving α receptor stimulation unopposed. This may lead to an increase in peripheral resistance and an increase in blood pressure.

Nor epinephrine Actions 1- Cardiovascular actions: Vasoconstriction: Norepinephrine causes a rise in peripheral resistance due to intense vasoconstriction of most vascular beds, including the kidney (α1 effect). Both systolic and diastolic blood pressures increase. [Note: Norepinephrine causes greater vasoconstriction than does epinephrine, because it does not induce compensatory vasodilation via β2 receptors on blood vessels supplying skeletal muscles, etc. The weak β2 activity of norepinephrine also explains why it is not useful in the treatment of asthma.]

Uses: Shock; because it increases vascular resistance and, therefore, increases blood pressure. However, dopamine and metaraminol is favored, because it does not reduce blood flow to the kidney, as does norepinephrine When norepinephrine is used as a drug, it is sometimes called levarterenol

Pharmacokinetics: Norepinephrine may be given IV for rapid onset of action. The duration of action is 1 to 2 minutes following the end of the infusion period. It is poorly absorbed after subcutaneous injection. destroyed in the gut if administered orally. Metabolism is similar to that of epinephrine. Adverse effects: These are similar to those of epinephrine.